Saber İmani
- Molecular Biology top 10%
- Cancer Research top 5%
- Oncology top 10%
- Pulmonary and Respiratory Medicine
- Immunology
- Co-authors
- Junjiang FuHossein HosseinifardJingliang ChengRay‐Chang WuChunli WeiShangyi FuQinglian WenMarzieh Dehghan Shasaltaneh
- Topics
- MicroRNA in disease regulation (7 papers)PI3K/AKT/mTOR signaling in cancer (5 papers)Cancer-related molecular mechanisms research (5 papers)
- Journals
- SHILAP Revista de lepidopterologíaScientific ReportsFrontiers in Immunology
- Partner nations
- ChinaIranUnited States
In The Last Decade
Saber İmani
79 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Molecular Biology 776
- Cancer Research 394
- Oncology 276
- Pulmonary and Respiratory Medicine 184
- Immunology 179
Countries citing papers authored by Saber İmani
This map shows the geographic impact of Saber İmani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saber İmani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saber İmani more than expected).
Fields of papers citing papers by Saber İmani
This network shows the impact of papers produced by Saber İmani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saber İmani. The network helps show where Saber İmani may publish in the future.
Co-authorship network of co-authors of Saber İmani
This figure shows the co-authorship network connecting the top 25 collaborators of Saber İmani. A scholar is included among the top collaborators of Saber İmani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saber İmani. Saber İmani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapybreakdown → | 26 |
| 2 | 5 | |
| 3 | 7 | |
| 4 | 6 | |
| 5 | 11 | |
| 6 | 2 | |
| 7 | 3 | |
| 8 | 20 | |
| 9 | 2 | |
| 10 | 25 | |
| 11 | 12 | |
| 12 | Comparison of IgG and IgA Antibodies Titrations against Helicobacter Pylori in Urban and Rural Populations in Mazandaran Province | 0 |
| 13 | 29 | |
| 14 | 4 | |
| 15 | Antibacterial Effect of CrO and CoFe2O4 Nanoparticles upon Staphylococcus aureus | 2 |
| 16 | 3 | |
| 17 | 39 | |
| 18 | LIPID PROFILE OF CHILDREN WITH TYPE I DIABETES COMPARED TO CONTROLS | 4 |
| 19 | EFFECT OF AGE, GENDER AND BLOOD GROUP ON BLOOD CANCER TYPES | 13 |
| 20 | Survey of some metabolic disorders in obese children and adolescents | 3 |
About Saber İmani
Saber İmani is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 81 papers that have together received 1.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Cancer-related molecular mechanisms research (5 papers). The work is most often cited by research in Cancer Research (394 citations), Molecular Biology (776 citations) and Oncology (276 citations). Saber İmani has collaborated with scholars based in China, Iran and United States. Frequent co-authors include Junjiang Fu, Hossein Hosseinifard, Jingliang Cheng, Ray‐Chang Wu, Chunli Wei, Shangyi Fu, Qinglian Wen, Marzieh Dehghan Shasaltaneh, Yunes Panahi and Youcai Deng. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.